NCT06639230
Effect of Laser and Sclerotic Agent in the Treatment of Oral Granuloma
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Postoperative pain was evaluated (NRS)
Timeframe: 3 months
Recurrence rate
Timeframe: 3 months
Patient compliance (VAS).
Timeframe: 3 months
Secondary (1)
Details of side effects
Arms and interventions
Group 1: Laser-treated groupActive comparator
10 patients will be treated by laser surgery to remove oral granuloma
Sclerotherapy-treated group (group 2)Active comparator
This group was made up of ten patients who were treated with injections of sclerosing agent to remove pyogenic granuloma
Devices: laser therapy
Drugs: Sclerotherapy